ZA935693B - Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists - Google Patents

Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists

Info

Publication number
ZA935693B
ZA935693B ZA935693A ZA935693A ZA935693B ZA 935693 B ZA935693 B ZA 935693B ZA 935693 A ZA935693 A ZA 935693A ZA 935693 A ZA935693 A ZA 935693A ZA 935693 B ZA935693 B ZA 935693B
Authority
ZA
South Africa
Prior art keywords
angiotensin
prodrugs
carboxylic acids
receptor antagonists
imidazole carboxylic
Prior art date
Application number
ZA935693A
Other languages
English (en)
Inventor
Robert John Ardecky
Carol Lee Ensinger
James Russell Pruitt
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of ZA935693B publication Critical patent/ZA935693B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA935693A 1992-08-06 1993-08-05 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists ZA935693B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/926,795 US5310929A (en) 1992-08-06 1992-08-06 Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists

Publications (1)

Publication Number Publication Date
ZA935693B true ZA935693B (en) 1995-02-06

Family

ID=25453732

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935693A ZA935693B (en) 1992-08-06 1993-08-05 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists

Country Status (18)

Country Link
US (1) US5310929A (enExample)
EP (1) EP0654027A1 (enExample)
JP (1) JP2892838B2 (enExample)
CN (1) CN1090275A (enExample)
AU (1) AU688735B2 (enExample)
BR (1) BR9306911A (enExample)
CA (1) CA2141692C (enExample)
FI (1) FI950485A7 (enExample)
HU (1) HU9500349D0 (enExample)
IL (1) IL106553A0 (enExample)
MX (1) MX9304787A (enExample)
NO (1) NO950404D0 (enExample)
PL (1) PL307309A1 (enExample)
SG (1) SG47108A1 (enExample)
SK (1) SK13195A3 (enExample)
TW (1) TW239131B (enExample)
WO (1) WO1994003435A1 (enExample)
ZA (1) ZA935693B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
HU219598B (hu) * 1992-12-17 2001-05-28 Sankyo Co. Ltd. Bifenilvegyületek imidazol- és piridinszármazékai, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
AU684916B2 (en) * 1994-03-16 1998-01-08 Sankyo Company Limited Ocular tension depressant
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US5510495A (en) * 1994-09-19 1996-04-23 The Du Pont Merck Pharmaceutical Company Process for the isolation and purification of ester functionalized imidazole intermediates by selective hydrolysis
ATE176784T1 (de) * 1994-09-20 1999-03-15 Wakunaga Seiyaku Kk Verfahren zur herstellung von n- biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
IT1295405B1 (it) * 1997-09-30 1999-05-12 Merck Sharp & Dohme Italia S P Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di
DE19820064A1 (de) * 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE19832428A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832429A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
CN1759113A (zh) * 2003-01-16 2006-04-12 特瓦制药工业有限公司 伊贝沙坦的新合成方法
CN1910284B (zh) 2004-01-20 2011-04-06 爱知县 由HLA-A2402-限制的Ep-CAM-特异的CTL识别的表位/肽及其应用
US7157584B2 (en) * 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
KR20090102883A (ko) * 2004-09-02 2009-09-30 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
CN101160126A (zh) * 2005-04-20 2008-04-09 默克公司 血管紧张肽ⅱ受体拮抗剂
JP2009515834A (ja) * 2006-08-29 2009-04-16 テバ ファーマシューティカル インダストリーズ リミティド ５−フェニル−１−トリチル−１ｈ−テトラゾールの合成のための方法
KR101458369B1 (ko) * 2006-10-09 2014-11-05 씨아이피엘에이 엘티디. 트리틸 올메사탄 메독소밀 및 올메사탄 메독소밀의 제조방법
EP2103610B1 (en) * 2006-12-06 2011-09-21 Shanghai Allist Pharmaceutical., Inc. Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
EP2521545B1 (en) 2010-01-07 2019-11-27 Alkermes Pharma Ireland Limited Prodrugs of heteroaromatic compounds
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
CN104610232B (zh) * 2013-11-01 2019-09-20 深圳信立泰药业股份有限公司 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
JP2022542437A (ja) 2019-08-02 2022-10-03 ランティオペプ ベスローテン ヴェンノーツハップ 癌の処置に用いるアンジオテンシン２型（ａｔ２）受容体アゴニスト

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
KR950009860B1 (ko) * 1989-06-30 1995-08-29 이. 아이. 듀퐁 드 네모아 앤드 캄파니 융합된 환 아릴 치환된 이미다졸과 약제학적으로 허용되는 이의 염, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물
KR0163595B1 (ko) * 1989-06-30 1998-12-01 미리암디, 메코너헤이 치환된 이미다졸
GB8927277D0 (en) * 1989-12-01 1990-01-31 Glaxo Group Ltd Chemical compounds
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5137902A (en) * 1990-07-13 1992-08-11 E. I. Du Pont De Nemours And Company 4-alkylimidazole derivatives and anti-hypertensive use thereof
ES2155827T3 (es) * 1992-06-02 2001-06-01 Sankyo Co 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico.

Also Published As

Publication number Publication date
CN1090275A (zh) 1994-08-03
HU9500349D0 (en) 1995-03-28
FI950485L (fi) 1995-02-03
AU4790393A (en) 1994-03-03
PL307309A1 (en) 1995-05-15
BR9306911A (pt) 1998-12-08
FI950485A0 (fi) 1995-02-03
NO950404D0 (no) 1995-02-03
JP2892838B2 (ja) 1999-05-17
WO1994003435A1 (en) 1994-02-17
TW239131B (enExample) 1995-01-21
SG47108A1 (en) 1998-03-20
FI950485A7 (fi) 1995-02-03
AU688735B2 (en) 1998-03-19
EP0654027A1 (en) 1995-05-24
US5310929A (en) 1994-05-10
MX9304787A (es) 1995-01-31
IL106553A0 (en) 1993-12-08
CA2141692C (en) 2006-05-30
JPH08500103A (ja) 1996-01-09
SK13195A3 (en) 1995-07-11
CA2141692A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
HU9500349D0 (en) Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists
IL105877A0 (en) Angiotensin ii antagonists
AU3122793A (en) Substituted heterocycles as angiotensin ii antagonists
EP0574787A3 (en) Benzimidazole derivatives as angiotensin ii antagonists
ZA912656B (en) Substituted benzimidazoles having angiotensin 11 receptor antagonisn
EP0475206A3 (en) Angiotensin ii receptor antagonists
EP0574846A3 (en) Imidazopyridines as angiotensin ii antagonistes
ZA943690B (en) Imidazole 5-position substituted angiotensin II antagonists
HU9302843D0 (en) Quinolone carboxylic acids
HUP9902645A3 (en) Fused-ring carboxylic acid derivatives
AU3276293A (en) Angiotensin II receptor antagonists
IL131812A0 (en) Salt of naphthyridine carboxylic acid derivative
GB9317760D0 (en) Angiotensin ii antagonist
ZA923279B (en) Substituted carboxylic acid derivatives
GB9317758D0 (en) Angiotensin ii antagonist
AU3440693A (en) Substituted 1-isoquinolone derivatives as angiotensin II antagonists
FI943807L (fi) Pyratsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vastavaikuttajina
IL109310A0 (en) Alkyl substituted nitroimidazole acetic acids
EP0591891A3 (en) Benzimidazole derivatives as angiotensin ii antagonists
PL314182A1 (en) 5-aryloisoxazol-4-yl substituted compounds of 2-amino carboxylic acids
IL110239A0 (en) Azacyclic - heterocyclic compounds as angiotensin II receptor antagonists
EP0546449A3 (en) Benzofuranderivatives as angiotensin ii antagonists
EP0595151A3 (en) Imidazopyridine derivates as antagonists of angiotensin ii
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
GB9303500D0 (en) Carboxylic acid esters fo hydroxyphenylalkanols as stabilisers